相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis
Richard Marcotte et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
A small-molecule inhibitor of D-cyclin transactivation displays preclinical efficacy in myeloma and leukemia via phosphoinositide 3-kinase pathway
Xinliang Mao et al.
BLOOD (2011)
Aurora Kinase Inhibitors Based on the Imidazo[1,2-a]pyrazine Core Fluorine and Deuterium Incorporation Improve Oral Absorption and Exposure
Angela D. Kerekes et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
The Tricyclic Antidepressant Amitriptyline Inhibits D-Cyclin Transactivation and Induces Myeloma Cell Apoptosis by Inhibiting Histone Deacetylases: In Vitro and In Silico Evidence
Xinliang Mao et al.
MOLECULAR PHARMACOLOGY (2011)
Phase I/II Study of the Src Inhibitor Dasatinib in Combination With Erlotinib in Advanced Non-Small-Cell Lung Cancer
Eric B. Haura et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Phase II Study of Dasatinib in Patients With Advanced Non-Small-Cell Lung Cancer
Faye M. Johnson et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
A chemical and phosphoproteomic characterization of dasatinib action in lung cancer
Jiannong Li et al.
NATURE CHEMICAL BIOLOGY (2010)
Understanding resistance to EGFR inhibitors-impact on future treatment strategies
Deric L. Wheeler et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2010)
Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells
Eun-Jung Park et al.
CANCER LETTERS (2009)
Lung Cancer Occurrence in Never-Smokers: An Analysis of 13 Cohorts and 22 Cancer Registry Studies
Michael J. Thun et al.
PLOS MEDICINE (2008)
A new model of patient tumor-derived breast cancer Xenografts for preclinical assays
Elisabetta Marangoni et al.
CLINICAL CANCER RESEARCH (2007)
Identification of candidate molecular markers predicting sensitivity in solid tumors to dasatinib: Rationale for patient selection
Fei Huang et al.
CANCER RESEARCH (2007)
Transcriptional targets of p53 that regulate cellular proliferation
Lauren Brown et al.
CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION (2007)
Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival
Lanxi Song et al.
CANCER RESEARCH (2006)
Derivatives of tramadol for increased duration of effect
LM Shao et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2006)
Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cells
FM Johnson et al.
CLINICAL CANCER RESEARCH (2005)
Src family protein-tyrosine kinases alter the function of PTEN to regulate phosphatidylinositol 3-kinase/AKT cascades
YL Lu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
pp60c-src activation in lung adenocarcinoma
T Masaki et al.
EUROPEAN JOURNAL OF CANCER (2003)
The protein kinase complement of the human genome
G Manning et al.
SCIENCE (2002)
V-SRC'S hold over actin and cell adhesions
MC Frame et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Exposure to a deuterated analogue of phenylbutyrate retards S-phase progression in HT-29 colon cancer cells
KO Clarke et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Role of Src expression and activation in human cancer
RB Irby et al.
ONCOGENE (2000)
分享论文
